Biaffin GmbH & Co KG - Biomolecular Interaction Analyses using SPR Biacore Biosensors

EU-funded project thera cAMP


EU-funded project for identification and characterisation of protein-protein interactions as target for new therapeutic molecules

Title: "Identification of therapeutic molecules to target compartmentalised cAMP signalling networks in human disease" (thera-cAMP)

Major human diseases are caused or are associated with disturbances of compartmentalised cyclic adenosine monophosphate (cAMP) signalling networks. The participants of the European research project "thera-cAMP" aim to identify lead compounds, which specifically modulate protein-protein interactions in such signalling cascades. The approach could lead to alternative strategies for the treatment for diseases that are currently not addressed effectively by conventional pharmacotherapy.

BIAFFIN GmbH & Co KG | Heinrich-Plett-Str. 40 | D-34132 Kassel | Germany
Tel.: +49 (0) 561-804 4661 | Fax: +49 (0) 561-804 4665 |